Medical News

RSS

Affordable Health Care Act to increase number of insured Americans by 36 million

According to Fitch Ratings' Fall U.S. Healthcare Sector Legislative and Regulatory Register, the Affordable Health Care for America Act of 2009 (H.R. 3962) passed by the House of Representatives on Nov. 7, 2009 will generally increase the number of insured Americans by 36 million through individual and employer mandates, coupled with a number of subsidies offered to lower-income individuals and smaller employers.

2 Dec 2009

ASH Annual Meeting to showcase latest research and treatments for blood disorders

The American Society of Hematology (ASH), the world's largest professional association of blood specialists, expects more than 20,000 attendees at the 51st ASH Annual Meeting from December 5-8, 2009, at the Ernest N. Morial Convention Center in New Orleans, LA. The meeting will showcase the latest research and treatments for blood disorders.

2 Dec 2009

Georgia Institute of Technology receives contract to design nanostructures and cognition tools

The Georgia Institute of Technology has been awarded a U.S. Air Force Center of Excellence to design nanostructures for energy harvesting and adaptive materials, and to develop tools to optimize critical cognitive processes of the modern warfighter.

2 Dec 2009

Baker College Online's new BSN degree program for registered nurses

Baker College Online officials today announced its new Baccalaureate of Science in Nursing (BSN) degree program. The BSN is based on accreditation standards established by the Commission on Collegiate Nursing Education (CCNE). Registration for the new program is now underway for winter 2010 quarter.

2 Dec 2009

70% of 350 US physicians will increase the use niacin for patients, says report

Sermo (http://www.sermo.com), the world's largest online physician's community, today announced the results of a new report indicating that 70% of 350 US physician respondents would increase their use of niacin based on results from the ARBITER 6-HALTS trial.

2 Dec 2009

BSGI effective in detecting malignant or high-risk lesions in patients with negative mammographic findings

Breast-Specific Gamma Imaging (BSGI) significantly contributes to the detection of malignant or high-risk lesions in patients with negative or indeterminate mammographic findings, according to results of a multicenter study presented today at the annual meeting of the Radiological Society of North America (RSNA).

2 Dec 2009

AHF protests against budget cuts to AIDS services

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, is joining a coalition of AIDS advocates and patients to protest drastic California budget cuts to lifesaving AIDS services—including California’s AIDS Drug Assistance Program (ADAP)—that is jeopardizing the public health by eliminating the vast majority of funding for AIDS care and treatment, including lifesaving AIDS drugs.

2 Dec 2009

New approach to identify molecules that prevent immune cells from attacking body

A study led by a Scripps Research Institute scientist describes a new, highly pragmatic approach to the identification of molecules that prevent a specific type of immune cells from attacking their host. The findings add a powerful new tool to the ongoing search for potential treatments for autoimmune diseases, such as multiple sclerosis (MS), as well as blood cancers, such as myeloid leukemia.

2 Dec 2009

FDA approves Schering-Plough's New Drug Application for ZEGERID OTC capsules

Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Schering-Plough HealthCare Products, Inc.’s, New Drug Application (NDA) for ZEGERID OTC™ Capsules (omeprazole/sodium bicarbonate) with a dosage strength of 20 mg of omeprazole for over-the-counter (OTC) treatment of frequent heartburn.

2 Dec 2009

Researchers develop new application for improved detection of breast cancer cells

Single-walled nanotubes—cylinders of carbon about a nanometer in diameter—have been highly touted for potential applications such as ultrastrong fibers, electrical wires in molecular devices, or hydrogen storage components for fuel cells. Thanks to a new development by researchers at the National Institute of Standards and Technology (NIST) and five partners, you can add one more application to the list: detection and destruction of an aggressive form of breast cancer.

2 Dec 2009

Boehringer Ingelheim to announce positive results from its RE-COVER study

Boehringer Ingelheim will announce positive results from the landmark RE-COVER™ study at the 51st Annual Meeting of the American Society of Hematology on 6 December 2009. The RE-COVER™ study assessed dabigatran etexilate in a head-to-head comparison with the current standard in care, warfarin, for the treatment of acute venous thromboembolism (VTE), enabling healthcare professionals to make direct comparisons and care based value judgements.

2 Dec 2009

Results from second Phase III placebo controlled study of EXPAREL announced

Pacira Pharmaceuticals, Inc., announced today that its second Phase III placebo controlled study of EXPAREL(TM) (DepoBupivacaine) met its primary endpoint.

2 Dec 2009

New nursing guideline to enhance improved care for MMT clients

A pregnant woman walks into a hospital in early labour. She feels nauseated and achy; her contractions are 20 minutes apart. There is more to her story than meets the eye. She is on methadone maintenance therapy (MMT) and wasn't able to pick up her daily dose at the pharmacy this morning. Although her story may be hard to believe she is one of the estimated 17,000 clients in Ontario currently receiving MMT.

2 Dec 2009

J&JPRD submits an NDA for tapentadol ER tablets

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol extended release (ER) tablets, an investigational oral analgesic for the management of moderate to severe chronic pain in patients 18 years of age or older.

2 Dec 2009

Despite price transparency legislation in California, uninsured patients do not receive price estimates

Uninsured patients in California are unable to successfully obtain information about the cost of medical care at hospitals despite recent state legislation intended to improve price transparency, according to a new study.

2 Dec 2009

DiaMedica to acquire all issued and outstanding shares of Sanomune

DiaMedica Inc. (TSX VENTURE:DMA)("Diamedica"), a biopharmaceutical company that has discovered and is developing a novel approach to treating diabetes, announces it has entered into a non-binding letter of intent to acquire all of the issued and outstanding shares of Sanomune Inc.

2 Dec 2009

Howard Leight dispels common misconceptions associated with hearing protection

In the world of personal protective equipment, bad assumptions are hazardous and can result in injury -- or worse. Yet, despite 25 years of government regulation, a handful of persistent bad assumptions are widespread -- endangering both the effectiveness of occupational Hearing Conservation Programs (HCPs) -- and worker hearing.

2 Dec 2009

MUHC researchers identify first genetic resistance factor against TB infection

Why do some people who are exposed to tuberculosis not become infected or develop the disease? Dr. Erwin Schurr and his team at the Research Institute from the McGill University Health Centre (RI-MUHC), in collaboration with Dr. Alexandre Alcais, from the Institut national de la sant- et de la recherche m-dicale (INSERM) in Paris, has shed light on this question for the first time. Their

2 Dec 2009

New preventive screening packages for heart disease

HealthYes!®, a leading mobile medical screening provider, is offering several new preventive screenings directly focused on heart disease. The new tests include: a six-lead electrocardiogram (EKG), cholesterol finger-stick, and 10-year Framingham Cardiac Risk Score as well as diabetes and liver function testing.

2 Dec 2009

ACMG welcomes SACGHS report on gene patenting and licensing practices

The American College of Medical Genetics (ACMG) has a long-standing position that genes are products of nature, and as such should not be patentable. ACMG has provided comments to the Secretary's Advisory Committee on Genetics Health and Society (SACGHS) about its views on an ongoing basis.

2 Dec 2009

Medical News

Affordable Health Care Act to increase number of insured Americans by 36 million

ASH Annual Meeting to showcase latest research and treatments for blood disorders

Georgia Institute of Technology receives contract to design nanostructures and cognition tools

Baker College Online's new BSN degree program for registered nurses

70% of 350 US physicians will increase the use niacin for patients, says report

BSGI effective in detecting malignant or high-risk lesions in patients with negative mammographic findings

AHF protests against budget cuts to AIDS services

New approach to identify molecules that prevent immune cells from attacking body

FDA approves Schering-Plough's New Drug Application for ZEGERID OTC capsules

Researchers develop new application for improved detection of breast cancer cells

Boehringer Ingelheim to announce positive results from its RE-COVER study

Results from second Phase III placebo controlled study of EXPAREL announced

New nursing guideline to enhance improved care for MMT clients

J&JPRD submits an NDA for tapentadol ER tablets

Despite price transparency legislation in California, uninsured patients do not receive price estimates

DiaMedica to acquire all issued and outstanding shares of Sanomune

Howard Leight dispels common misconceptions associated with hearing protection

MUHC researchers identify first genetic resistance factor against TB infection

New preventive screening packages for heart disease

ACMG welcomes SACGHS report on gene patenting and licensing practices

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News